Molly Shoichet, PhD - University of Toronto
Professor Molly Shoichet holds the Tier 1 Canada Research Chair in Tissue Engineering at the University of Toronto. Her research is focused on drug and cell delivery strategies in the central nervous system and 3D hydrogel culture systems to model cancer. Dr. Shoichet co-founded four spin-off companies, is actively engaged in translational research and science outreach. She is an Officer of the Order of Canada and holds the Order of Ontario. Dr. Shoichet is a University Professor – the
highest distinction of the University of Toronto, which is held by less than 2% of the faculty. Dr. Shoichet received her SB from the Massachusetts Institute of Technology (1987) and her PhD from the University of Massachusetts, Amherst in Polymer Science and Engineering (1992).
Lisa Mielniczuk, MD - University of Ottawa Heart Institute, Ottawa ON
Dr. Mielniczuk is the Director of the Advanced Heart Diseases Program at the Ottawa Heart Institute. She is also cross-appointed to the Department of Cellular and Molecular Medicine. In 2019 Dr. Mielniczuk was appointed Vice-Chair of Patient Quality, Safety and Innovation for the Department of Medicine at the University of Ottawa. Her commitment to leadership and program development is evident in her multiple accomplishments at the Heart Institute, including being the co-Founder and Director of the Pulmonary Hypertension Program, developing a Rapid Intervention Clinic for HF patients, and a Regional HF program for the Ottawa/Champlain region. Provincially and Nationally, Dr. Mielniczuk is an active leader for the HF and Pulmonary Hypertension community, and currently sits as a member of the CorHealth Ontario Senior Leadership Council for Cardiac Disease, as well as serving as an expert panel member for Health Quality Ontario and CADTH.